Last edition
News about
IPC Signs MoU with UPPPC to Strengthen Quality, Innovation, and Regulatory Excellence in Healthcare
The Indian Pharmacopoeia Commission (IPC) has signed a Memorandum of Understanding (MoU) with Uttar Pradesh Promote Pharma Council (UPPPC) to enhance pharmaceutical quality, healthcare innovation, regulatory compliance, and MSME support through digital reporting tools.
UK and EU Drug Regulators Sign Working Arrangement
The UK government and the EU Drugs Agency have signed a working arrangement to strengthen regulatory cooperation, protect public health, and reduce drug-related harms.
Innovent Biologics Licenses Anti-CD40L Therapy IBI355 to Spero Therapeutics in USD 1.1 Billion Deal
Innovent Biologics has licensed global rights outside Greater China for its anti-CD40L antibody IBI355 to Spero Therapeutics in a deal valued at up to USD 1.1 billion, advancing the development of a potential new treatment for autoimmune diseases including IgG4-related disease and Sjögren's disease.
Can-Fite BioPharma Secures Australian Patent for Namodenoson in Advanced Metastatic Cancer
Can-Fite BioPharma has secured an Australian patent covering the use of Namodenoson for advanced metastatic cancer, strengthening intellectual property protection as the drug advances through late-stage clinical development for liver and pancreatic cancers.
UK and EU Drugs Agency Sign Pact to Strengthen Response to Emerging Drug Threats
The UK government and the European Union Drugs Agency (EUDA) have signed a new cooperation agreement to enhance intelligence sharing on emerging drug threats, strengthen public health protection and improve coordinated action against illicit drug trafficking across Europe.
Leiutis Pharma Wins CDSCO Approval for World's First Synthetic CBD Anxiety Therapy
Leiutis Pharmaceuticals has received CDSCO approval for the world's first synthetic CBD oral solution to treat mild to moderate anxiety disorders alongside cognitive behavioral therapy.
Formycon and OneSource Partner to Manufacture Biosimilars
Formycon and OneSource Specialty Pharma have partnered to manufacture biosimilars, with OneSource providing integrated Drug Substance (DS) and Drug Product (DP) manufacturing from its Bengaluru biologics facility.
AstraZeneca Enters into Global License Agreement with with Dizal Pharmaceutical for Zegfrovy
AstraZeneca has entered a global licensing agreement with Dizal Pharmaceutical for Zegfrovy, expanding its EGFR-targeted lung cancer portfolio.
Sun Pharma Receives Approval to Manufacture and Market Generic Semaglutide in South Africa
Sun Pharma has received approval to manufacture and market generic semaglutide in South Africa, available as a once-weekly pre-filled multi-dose injectable pen in 2 strengths.
NATCO Pharma Acquires Additional 13.25 Percent Stake in Adcock Ingram
NATCO Pharma has completed the acquisition of an additional 13.25 percent stake in South Africa's Adcock Ingram, strengthening its strategic investment in the pharmaceutical company.
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy